Embedded Cybersecurity Challenges in Medical Devices

Updated November 15, 2024

Embedded medical devices face security problems that enterprise IT never has to solve. Battery limits, tight memory, deterministic timing, intermittent connectivity, and long field life all change what is practical-and what the FDA expects you to justify in a premarket submission.

That is where many teams get into trouble. Under Section 524B, the September 2023 FDA premarket cybersecurity guidance, IEC 81001-5-1, and AAMI TIR57, reviewers are looking for evidence that you understood those embedded constraints and designed around them inside a working SPDF.

Key Takeaways

• Address unique embedded constraints in device security.
• Show how security aligns with safety and essential performance.
• Detail hardware trust, software assurance, comms security.
• Account for human factors in security control design.
• Evidence choices for the FDA under their premarket guidance.
• Integrate security into system design, not just documentation.

What Embedded Cybersecurity Means for Medical Devices

Embedded cybersecurity is the discipline of protecting software, hardware, interfaces, communications, and update mechanisms in devices built on constrained platforms. In medical devices, that means more than stopping malware. It means preserving safety, essential performance, data integrity, availability, and recoverability when the device is under attack or when a security control fails.

These systems are not laptops in smaller boxes. They are purpose-built devices running RTOSs, bare-metal code, Linux variants, or mixed architectures tied to sensors, actuators, and clinical workflows. They often have limited compute resources, specialized hardware interfaces, and deployment lifecycles that stretch for years.

For manufacturers, the core challenge is simple to state and hard to execute: add effective security controls without breaking safety, timing, usability, battery life, manufacturability, or serviceability. That tradeoff needs to be engineered, documented, tested, and traceable to risk decisions the FDA reviewers can follow.

Where Embedded Device Cybersecurity Usually Breaks Down

Most embedded cybersecurity failures fall into a few recurring categories: hardware trust, software assurance, communications security, and operational reality. The details vary by product. The patterns do not.

Hardware Constraints and Physical Exposure

Many devices cannot absorb heavyweight security controls without consequences. Stronger crypto may increase boot time. Extra logging may wear flash faster. Continuous monitoring may drain battery. Secure storage may require a component with supply chain and cost implications. Real constraints. Not excuses.

Physical access also matters more in embedded systems than many teams admit. Service ports, debug interfaces, removable media, exposed buses, and manufacturing hooks can all become attack paths if they are left enabled or weakly controlled. A device in a hospital, ambulance, home, or lab may be touched by users, technicians, third-party maintainers, or attackers with time and tools.

That is why reviewers often expect to see:

• trust anchors and key protection tied to the device architecture
• decisions around secure boot and measured integrity
• controls for JTAG, UART, test pads, and maintenance interfaces
• tamper response, where appropriate
• rationale when hardware security features were not included

If you cannot support a control because of device limitations, explain the limitation and show the compensating controls. Do not leave a gap and hope nobody notices.

Software Weaknesses in Constrained Environments

Embedded software tends to inherit risk from age, reuse, and integration. Legacy code, third-party libraries, outdated kernels, vendor SDKs, and hand-rolled update logic create attack paths quickly. Add rushed release schedules and poor SBOM discipline, and the problem compounds.

The harder issue is that many standard security patterns are not drop-in fits for embedded platforms. Key rotation may be difficult in intermittently connected devices. Certificate validation may break if timekeeping is unreliable. Logging may be too sparse for incident response. Memory-safe redesign may not be practical in late-stage products. That does not remove the obligation to manage risk. It changes how you need to show your work.

Manufacturers should be ready to evidence:

• secure coding practices and code review expectations
• static, dynamic, and fuzz testing where applicable
• vulnerability handling for third-party components
• SBOM generation and maintenance
• secure configuration defaults
• documented security architecture decisions, especially where constraints drove tradeoffs

A submission gets stronger when those artifacts connect. Threats should map to controls, controls to verification, and unresolved residual risk to documented rationale.

Communications and Update Integrity

Connected devices bring predictable problems: weak authentication, poor key handling, insecure pairing, unprotected local services, and update mechanisms that trust too much. Wireless stacks and cloud integrations widen the attack surface, but wired service channels and internal hospital networks can be just as risky.

Too many products still treat encryption as the finish line. It is not. If the device cannot authenticate the sender, verify firmware authenticity, protect keys, prevent rollback, and fail safely during interrupted updates, you still have a serious problem.

For embedded medical devices, secure update design usually deserves its own threat analysis and verification set. Reviewers may look for:

• authenticated and integrity-checked firmware updates
• anti-rollback protections
• separation between update authority and transport channel
• behavior for partial, failed, or malicious updates
• recovery paths that preserve safety
• plans for patch deployment across the supported device life

If your patch story depends on field service visits, say so. If home-use devices may be offline for long periods, address that. The FDA is not looking for abstract best practices. The FDA is looking for whether your actual deployment model was considered.

Human Factors Still Matter

Security failures are not always technical. Sometimes the control exists but the workflow defeats it.

A clinician under time pressure may bypass a pairing step. A technician may use a shared service credential. A home user may ignore an update prompt because the instructions are unclear. A hospital may leave the device on a flat network because segmentation guidance was vague or unrealistic.

Human factors belong in embedded cybersecurity because the device is part of a real care environment. Security controls that cannot be used correctly will fail in practice, no matter how polished they look in design documentation.

That means manufacturers should consider:

• secure defaults that do not rely on expert users
• role-appropriate authentication and service access
• clear update and maintenance workflows
• labeling and instructions that match the intended environment
• training needs for operators, admins, and servicers

This is also where anti-checklist-theater matters. Telling users to “follow cybersecurity best practices” is not a control. Designing a workflow they can actually perform is.

What Good Technical Solutions Look Like

Technical solutions for embedded devices need to fit the platform, the threat model, and the safety case. Security features that degrade essential performance or introduce new clinical risk are not automatically wins.

At the hardware level, useful controls may include secure elements, hardware-backed key storage, trusted execution support, memory protection features, and interface lockdown for production units. At the software level, the basics still matter: hardened configurations, signed code, input validation, least privilege, dependency management, and tested recovery behavior.

The key is not collecting security features. It is showing that the selected controls address plausible threats on the actual device architecture.

For many submissions, the stronger evidence package includes:

• system and security architecture diagrams
• trust boundary definitions
• threat models tied to assets, attack paths, and abuse cases
• security requirements derived from risk analysis
• verification evidence for each implemented control
• unresolved gaps tracked through risk management and postmarket planning

That is the difference between “we use secure boot” and “here is how boot trust is established, verified, maintained, and tested across the product lifecycle.”

Standards, Policy, and What the FDA Expects

Medical device manufacturers do not need more generic cybersecurity slogans. They need artifacts that align with current regulatory expectations.

The FDA’s premarket cybersecurity guidance points manufacturers toward an SPDF-based approach. Section 524B raises the floor by requiring cybersecurity information in covered submissions, including processes for vulnerability management, design controls for cybersecurity, and evidence such as SBOM-related content. IEC 81001-5-1 helps structure secure product development activities. AAMI TIR57 remains useful for threat modeling and security risk management. The NIST Cybersecurity Framework can still support broader program alignment, but it does not replace device-specific design evidence.

For embedded products, that evidence must account for the things reviewers question most often:

• why a control was selected or omitted
• how constraints affected implementation
• how security interacts with safety and essential performance
• how updates will work in the field
• how known vulnerabilities in included components are handled
• how postmarket monitoring feeds back into the product lifecycle

If your documentation reads like a template pasted onto a constrained device, expect friction. Embedded products need embedded-specific rationale.

Final Take

Embedded cybersecurity in medical devices is not a side topic. It is where architecture, safety, usability, service, and regulatory strategy collide.

Teams that do this well do not treat security as a late documentation exercise. They build it into system design, verify it under realistic operating conditions, and produce evidence that matches how the device will actually be deployed and maintained. That is what supports a defensible submission under Section 524B and what holds up better after release.

Blue Goat Cyber helps manufacturers do that work in a way that stands up to scrutiny from the FDA, aligns with IEC 62304 and EU MDR obligations, and reflects how embedded devices really behave in the field. If embedded cybersecurity issues are putting your submission, launch timeline, or postmarket plan at risk, contact us today for cybersecurity help.

FAQs

What are embedded cybersecurity challenges in medical devices?

Embedded medical devices face challenges like limited battery, memory, processing power, intermittent connectivity, and long field life. These constraints impact the implementation of security controls while maintaining safety and essential performance, differentiating them from enterprise IT systems.

How does the FDA evaluate embedded cybersecurity in medical devices?

The FDA evaluates embedded cybersecurity through an SPDF-based approach, looking for evidence that manufacturers understood and designed around embedded constraints. Submissions must connect threats to controls, controls to verification, and unresolved residual risk to documented rationale.

Why is hardware trust important for embedded medical devices?

Hardware trust is crucial because physical access to embedded devices can expose vulnerabilities through service ports, debug interfaces, or removable media. Manufacturers should provide rationale for trust anchors, key protection, secure boot decisions, and controls for physical interfaces.

What role do software weaknesses play in embedded device cybersecurity?

Embedded software often inherits risk from legacy code, third-party components, and outdated systems, creating attack paths. Standard security patterns may not fit, requiring manufacturers to demonstrate secure coding, testing, vulnerability handling, and documented security architecture decisions.

How should medical device manufacturers approach secure updates?

Secure update design for medical devices requires a dedicated threat analysis. Manufacturers must show authenticated and integrity-checked firmware updates, anti-rollback protections, and clear plans for patch deployment, considering the actual deployment model and field conditions.

Does human factors affect embedded cybersecurity?

Yes, human factors significantly impact embedded cybersecurity. Security controls must be usable within real clinical workflows. Manufacturers should design for secure defaults, role-appropriate authentication, clear instructions, and training to ensure controls function effectively in practice.

Related: UEFI Secure Boot for Medical Devices